SCHEMBL30936690

SCHEMBL30936690

CC1CCC(N(C)c2ccccc2N)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.42
USP2 O75604 1/20 0.42
GAA P10253 1/20 0.42
KMT2A Q03164 1/20 0.42
JAK1 P23458 1/20 0.39
JAK3 P52333 1/20 0.39
CHEK1 O14757 1/20 0.35
NEK2 P51955 1/20 0.35
LIMK1 P53667 1/20 0.35
DYRK1A Q13627 1/20 0.35
CLK4 Q9HAZ1 1/20 0.35
FFAR2 O15552 1/20 0.32
CYP3A4 P08684 1/20 0.31
ALOX15 P16050 1/20 0.31
CASP1 P29466 1/20 0.31
CASP7 P55210 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
ALDH1A1 P00352 1/20 0.31
HPGD P15428 1/20 0.31
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30936629 0.85 LMNA (0.40) MEN1USP2GAAKMT2AJAK1
SCHEMBL8564451 0.84 GAA (0.41) MEN1USP2GAAKMT2AJAK1
SCHEMBL31720693 0.81 FFAR2 (0.40) MEN1USP2GAAKMT2ACHEK1
SCHEMBL6197806 0.80 CHEK1 (0.36) MEN1USP2GAAKMT2AJAK1
SCHEMBL30936653 0.75 POLB (0.38) MEN1GAAKMT2AJAK1JAK3
SCHEMBL5479824 0.73 DDB1 (0.40) GAACYP3A4SLC6A2SLC6A4SLC6A3
SCHEMBL10109668 0.73 JAK1 (0.40) MEN1KMT2AJAK1JAK3ALDH1A1
SCHEMBL28064511 0.72 CYP3A4 (0.39) MEN1USP2GAAKMT2ACHEK1
SCHEMBL27648288 0.72 CHEK1 (0.32) CHEK1NEK2LIMK1DYRK1ACLK4
SCHEMBL31720579 0.72 ACHE (0.46) MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250340510-A1 Substituted Phenylbenzenesulfonamide Derivatives and Uses Thereof NINE SQUARE THERAPEUTICS CORPORATION (US) 2025-11-06 US disclosed
EP-4608389-A2 SUBSTITUTED PHENYLBENZENESULFONAMIDE DERIVATIVES AND USES THEREOF Nine Square Therapeutics Corporation (US) 2025-09-03 EP disclosed
WO-2024092235-A2 SUBSTITUTED PHENYLBENZENESULFONAMIDE DERIVATIVES AND USES THEREOF NINE SQUARE THERAPEUTICS CORPORATION (US) 2024-05-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250340510-A1 Substituted Phenylbenzenesulfonamide Derivatives and Uses Thereof TRPM2, TRPM6, TRPM5 MEN1 2343/4885USP2 3030/4885GAA 627/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.